XTL Biopharmaceuticals Sponsored ADR share price logo

XTL Biopharmaceuticals Sponsored ADR

NASDAQ: XTLB

$2.76

-0.22

(-7.32%)

as on

XTL Biopharmaceuticals Sponsored ADR Stock Performance

as on August 21, 2026 at 6:59 am IST

  • Day's High

    $2.76
    $3.05

    10.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.01
    $10.28
    downward going graph

    27.17%

    Downside

    272.45%

    Upside

    downward going graph

XTL Biopharmaceuticals Sponsored ADR share price movements today

Previous Close
$2.98
Open
$2.85
Volume
83.5K
Market Cap
$6.8M
Day's Low - High
$2.76 - $3.05
52 Week Low - High
$2.01 - $10.28

XTL Biopharmaceuticals Sponsored ADR Historical Returns

1 Month Return
-1.94 %
3 Month Return
+ 6.7 %
1 Year Return
-50.62 %
3 Year Return
-27.93 %
5 Year Return
-80.87 %

XTL Biopharmaceuticals Sponsored ADR Stock Fundamentals & Key Indicators

Check XTL Biopharmaceuticals Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.8M

EPS (TTM)

-2.88

Dividend Yield

0.00%

PE Ratio (TTM)

-0.84

Industry PE ratio

-3.712675585284281

PEG Ratio

0.009840599053220486

Return On Equity TTM

-269.02%

XTL Biopharmaceuticals Sponsored ADR Stock Valuation

Track how XTL Biopharmaceuticals Sponsored ADR P/E has moved over time to understand its valuation trends.

XTL Biopharmaceuticals Sponsored ADR in the last 5 years

  • Overview

  • Trends

Lowest (-772.17x)

December 31, 2023

Industry (-3.71x)

December 31, 2025

Today (-0.14x)

December 31, 2025

Highest (8.47x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -0.14x

XTL Biopharmaceuticals Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XTL Biopharmaceuticals Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$6.8M-80.87%-0.840.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for XTL Biopharmaceuticals Sponsored ADR Stock including INR - Dollar returns

The XTL Biopharmaceuticals Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

XTL Biopharmaceuticals Sponsored ADR investment value today

Current value as on today

₹53,816

Returns

-₹46,184

(-46.18%)

Returns from XTL Biopharmaceuticals Sponsored ADR Stock

-₹51,064 (-51.06%)

Dollar Impact

₹4,880 (+4.88%)

Indian Investors' Interest in XTL Biopharmaceuticals Sponsored ADR Stock

Search interest for XTL Biopharmaceuticals Sponsored ADR Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

XTL Biopharmaceuticals Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
0
0
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
Interest Expense
-
-
0
0
0
-
0
0
0
0
Depreciation
0
0
0
0
0
0
0
-
0
0
Income Before Tax
0
0
0
0
0
0
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
0
Net Income
0
0
0
0
0
0
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
-14.88%

XTL Biopharmaceuticals Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
0
-
Gross Profit
-
-
-
0
0
0
-
0
-
Operating Income
-1
0
0
0
-1
0
0
-2
-1
EBITDA
-1
0
-
0
-1
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
-
Income Before Tax
0
2
-1
-2
0
-1
-1
-1
0
Income Tax Expense
-
0
0
-
-
-
-
0
-
Net Income
0
2
-1
0
0
-1
0
-1
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.67%
0.00%

XTL Biopharmaceuticals Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Net Income
0
0
0
0
0
0
0
0
0
0
Operating Cash Flow
-
-
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
0
0
-4
-
-
-
-

XTL Biopharmaceuticals Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
2
-1
-2
0
-1
-1
-1
-6
Operating Cash Flow
-1
0
0
0
-1
0
0
-1
-1
Investing Cash Flow
-2
0
2
0
0
0
0
0
0
Financing Cash Flow
4
-
-
-
0
-
-
1
0
Change in Cash
1
0
1
0
0
0
0
-1
0

Global Institutional Holdings in XTL Biopharmaceuticals Sponsored ADR

Funds
Holdings
Citadel Advisors Llc
0%
UBS Group AG
0%
Noked Israel Ltd
2.02%
SmartHarvest Portfolios, LLC
0.54%
GAMMA Investing LLC
0.14%

Insights on XTL Biopharmaceuticals Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XTLB stock has moved up by 6.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 647.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 534.5%

About XTL Biopharmaceuticals Sponsored ADR

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.
OrganisationXTL Biopharmaceuticals Sponsored ADR
Headquarters85 Medinat Hayehudim St., Herzliya, Israel, 4676670
IndustryBiotechnology
CEOMr. Noam Band
E-voting on sharesClick here to vote

Key Management of XTL Biopharmaceuticals Sponsored ADR

Name

Title

Mr. Noam Band

CEO & Director

Mr. Segal Niv CPA

Chief Financial Officer

FAQs

What is XTL Biopharmaceuticals Sponsored ADR share price today?

XTL Biopharmaceuticals Sponsored ADR share price today is $2.76 as on at the close of the market. XTL Biopharmaceuticals Sponsored ADR share today touched a day high of $3.05 and a low of $2.76.

What is the 52 week high and 52 week low for XTL Biopharmaceuticals Sponsored ADR share?

XTL Biopharmaceuticals Sponsored ADR share touched a 52 week high of $10.28 on and a 52 week low of $2.01 on . XTL Biopharmaceuticals Sponsored ADR stock price today i.e. is closed at $2.76,which is 73.15% down from its 52 week high and 37.31% up from its 52 week low.

What is XTL Biopharmaceuticals Sponsored ADR's market capitalisation today?

XTL Biopharmaceuticals Sponsored ADR market capitalisation is $0.00T as on .

How to invest in XTL Biopharmaceuticals Sponsored ADR Stock (XTLB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XTL Biopharmaceuticals Sponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in XTL Biopharmaceuticals Sponsored ADR Shares that will get you 0.5435 shares as per XTL Biopharmaceuticals Sponsored ADR share price of $2.76 per share as on August 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy XTL Biopharmaceuticals Sponsored ADR Stock (XTLB) from India?

Indian investors can start investing in XTL Biopharmaceuticals Sponsored ADR (XTLB) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in XTL Biopharmaceuticals Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on XTL Biopharmaceuticals Sponsored ADR share’s latest price of $2.76 as on August 21, 2026 at 1:29 am IST, you will get 3.6232 shares of XTL Biopharmaceuticals Sponsored ADR. Learn more about fractional shares .

What are the returns that XTL Biopharmaceuticals Sponsored ADR has given to Indian investors in the last 5 years?

XTL Biopharmaceuticals Sponsored ADR stock has given -80.87% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?